Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

PHASE3CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Acromegaly
Interventions
DRUG

Octreotide capsules

Octreotide was provided in hard gelatin capsules.

Trial Locations (36)

1062

Military Hospital, State Health Center 2nd Department of Internal Medicine, Budapest

1088

Semmelweiss University, Budapest

1525

Department of Endocrinology and Diabetes, University Medical Centre, Ljubliana

5300

Centro Medico ABC, Mexico City

6720

University of Szeged, Szeged

7624

University of Pecs, Pécs

8661

Vilnius University Hospital Santariskiu Clinics Center of Endocrinology, Vilnius

10126

Ospedale Molinette, Torino

11000

Clinic for Endocrinology, Diabetes and Metabolism Diseases, Clinical Center of Serbia, Belgrade

11863

Endocrinology Institute C.I.Parhon, Bucharest

14269

Instituto Nacional de Neurologia y Neurocirugía - National Institute of Neurology and Neurosurgery, Mexico City

20357

ENDOC Center for Endocrine Tumors, Hamburg

21000

Clinical Center of Vojvodina, Novi Sad

25128

Servizio di Endocrinologia A.O. Spedali Civili di Brescia, Brescia

26122

Praxis for Endocrimology and Diabetology in Oldenburg, Oldenburg

44150

Unidad de Investigacion Clinica Cardiometabolica de Occidente, Guadalajara Jalisco

50009

Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

80336

Medizinische Klinik Innenstadt, Munich

80804

Max Planck Institute of Psychiatry, Munich

90048

Cedars-Sinai Medical Center, Los Angeles

98125

Dipartimento Clinico Sperimentale di Medicina e Farmacologia, Messina

700111

County Emergency Hospital, Sf. Spiridon, Department of Endocrinology, Iași

Unknown

Campus Charité Mitte, Berlin

2333 ZA

Leiden University Medical Centre, Leiden

3015 CE

Erasmus University Medical Center, Rotterdam

40- 952

Autonomous Public Clinical Hospital No. 5, Katowice

31-501

Department of Endocrinology - Jagiellonian University, Krakow, Krakow

60-355

Clinical Hospital of Medical University in Poznan, Poznan

01 - 809

Bielanski Hospital, Warsaw

50-367

Wroclaw Medical University, Wroclaw

833 05

University Hospital Bratislava, Hospital of L.Derer, Bratislava

034 91

National Institute of Endocrinology and Diabetology, Ľubochňa

CV2 2DX

University of Warwick - Medical School, Coventry

EC1M 6BQ

St Bartholomew's Hospital West, London

M13 9WL

The Christie Hospital NHS Trust, Manchester

OX37LJ

Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford

All Listed Sponsors
lead

Chiasma, Inc.

INDUSTRY

NCT01412424 - Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly | Biotech Hunter | Biotech Hunter